← Open Payments lookup

JENNIFER LEMAN: Open Payments

NPI 1518201466 · MEDIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,470 in 113 payments from 18 companies in 2025. Trend: 2023 $1,926 · 2024 $1,495 · 2025 $2,470

Food & beverage: $2,470
CompanyPaymentsAmount
ABBVIE INC.28$417
Madrigal Pharmaceuticals5$370
Janssen Biotech, Inc.18$325
GENZYME CORPORATION9$264
Takeda Pharmaceuticals U.S.A., Inc.12$258
Salix Pharmaceuticals, a division of Bausch Health US, LLC10$155
Phathom Pharmaceuticals, Inc.6$121
Ardelyx, Inc.6$119
Aimmune Therapeutics, Inc.3$95
PFIZER INC.5$94

Products named: REZDIFFRA, TREMFYA, DUPIXENT, RINVOQ, ENTYVIO, XIFAXAN, VOQUEZNA, IBSRELA.

Industry payments across PA — which companies pay providers there.